Biological therapy for multiple myeloma

Camilo Ayala-Breton; Stephen J. Russell; Kah Whye Peng

doi:10.1007/978-1-4614-8520-9_13

Biological therapy for multiple myeloma

Camilo Ayala-Breton, Stephen J. Russell, Kah Whye Peng

Molecular Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The National Cancer Institute defines biological therapy as: “A form of treatment that implies the administration of substances which produce a biological reaction in the organism thus enhancing or restoring the host immune response, modifying the behavior of cancer cells, blocking the pathways of cell neoplastic transformation and tumor ability to metastasize, or facilitating the repair of cells damaged by aggressive forms of cancer treatment. It includes the use of sera, antitoxins, vaccines, genes, cells, tissues, and organs.” In this chapter we will highlight different biological therapies that have been recently used against multiple myeloma (MM).

Original language	English (US)
Title of host publication	Multiple Myeloma
Subtitle of host publication	Diagnosis and Treatment
Publisher	Springer New York
Pages	141-158
Number of pages	18
ISBN (Electronic)	9781461485209
ISBN (Print)	9781461485193
DOIs	https://doi.org/10.1007/978-1-4614-8520-9_13
State	Published - Jan 1 2014

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4614-8520-9_13

Cite this

@inbook{20e877bc44254802b9f32f62650e077a,

title = "Biological therapy for multiple myeloma",

abstract = "The National Cancer Institute defines biological therapy as: “A form of treatment that implies the administration of substances which produce a biological reaction in the organism thus enhancing or restoring the host immune response, modifying the behavior of cancer cells, blocking the pathways of cell neoplastic transformation and tumor ability to metastasize, or facilitating the repair of cells damaged by aggressive forms of cancer treatment. It includes the use of sera, antitoxins, vaccines, genes, cells, tissues, and organs.” In this chapter we will highlight different biological therapies that have been recently used against multiple myeloma (MM).",

author = "Camilo Ayala-Breton and Russell, {Stephen J.} and Peng, {Kah Whye}",

note = "Publisher Copyright: {\textcopyright} Mayo Foundation for Medical Education and Research 2014.",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-1-4614-8520-9_13",

language = "English (US)",

isbn = "9781461485193",

pages = "141--158",

booktitle = "Multiple Myeloma",

publisher = "Springer New York",

}

TY - CHAP

T1 - Biological therapy for multiple myeloma

AU - Ayala-Breton, Camilo

AU - Russell, Stephen J.

AU - Peng, Kah Whye

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The National Cancer Institute defines biological therapy as: “A form of treatment that implies the administration of substances which produce a biological reaction in the organism thus enhancing or restoring the host immune response, modifying the behavior of cancer cells, blocking the pathways of cell neoplastic transformation and tumor ability to metastasize, or facilitating the repair of cells damaged by aggressive forms of cancer treatment. It includes the use of sera, antitoxins, vaccines, genes, cells, tissues, and organs.” In this chapter we will highlight different biological therapies that have been recently used against multiple myeloma (MM).

AB - The National Cancer Institute defines biological therapy as: “A form of treatment that implies the administration of substances which produce a biological reaction in the organism thus enhancing or restoring the host immune response, modifying the behavior of cancer cells, blocking the pathways of cell neoplastic transformation and tumor ability to metastasize, or facilitating the repair of cells damaged by aggressive forms of cancer treatment. It includes the use of sera, antitoxins, vaccines, genes, cells, tissues, and organs.” In this chapter we will highlight different biological therapies that have been recently used against multiple myeloma (MM).

UR - http://www.scopus.com/inward/record.url?scp=84956518758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956518758&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8520-9_13

DO - 10.1007/978-1-4614-8520-9_13

M3 - Chapter

AN - SCOPUS:84956518758

SN - 9781461485193

SP - 141

EP - 158

BT - Multiple Myeloma

PB - Springer New York

ER -

Biological therapy for multiple myeloma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this